News in brief: Canopy expands Australian portfolio; Neurotech CEO departs; Elixinol completes US sale by Adam Sheldon September 8, 2026September 9, 2026 Nasdaq and Toronto-listed Canopy Growth has expanded its Australian portfolio with a suite of new products, […]
